U. Urleb
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Synthesis and Characterization of Heterocyclic Compounds 20
- Quinazolinone synthesis and applications 10
- Synthesis and Reactivity of Heterocycles 8
- Carbohydrate Chemistry and Synthesis 6
-
- Chemical Synthesis and Analysis 15
- Co-authors
- Stanislav Gobec (18 shared papers)Miha Kotnik (6 shared papers)Didier Blanot (5 shared papers)Martin Everett (1 shared paper)Mark H. Wilcox (1 shared paper)Tomaž Bratkovič (6 shared papers)Christopher J. Schofield (1 shared paper)Patrice Courvalin (1 shared paper)
In The Last Decade
U. Urleb
101 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 113
- Molecular Medicine 152
- Applied Microbiology and Biotechnology 44
- Pharmaceutical Science 86
- Organic Chemistry 392
- Microbiology 74
Countries citing papers authored by U. Urleb
This map shows the geographic impact of U. Urleb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Urleb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Urleb more than expected).
Fields of papers citing papers by U. Urleb
This network shows the impact of papers produced by U. Urleb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Urleb. The network helps show where U. Urleb may publish in the future.
Co-authors
The 25 scholars most cited alongside U. Urleb, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 197 | |
| 2 | 2007 | 81 | |
| 3 | 2008 | 67 | |
| 4 | 2006 | 41 | |
| 5 | 1992 | 37 | |
| 6 | 2010 | 35 | |
| 7 | 2008 | 33 | |
| 8 | 2007 | 32 | |
| 9 | 2010 | 28 | |
| 10 | 2007 | 25 | |
| 11 | 2004 | 24 | |
| 12 | 2000 | 24 | |
| 13 | 2005 | 21 | |
| 14 | 2008 | 21 | |
| 15 | 2005 | 20 | |
| 16 | 2009 | 19 | |
| 17 | 2001 | 18 | |
| 18 | 2008 | 18 | |
| 19 | 2006 | 17 | |
| 20 | Synthesis and biochemical evaluation of some novel N-acyl phosphono- and phosphinoalanine derivatives as potential inhibitors of the D-glutamic acid-adding enzyme. | 2001 | 17 |
About U. Urleb
U. Urleb is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Analytical Chemistry and Pharmacology, having authored 103 papers that have together received 1.3k indexed citations. Recurring topics across this work include Synthesis and Characterization of Heterocyclic Compounds (20 papers), Chemical Synthesis and Analysis (15 papers), Quinazolinone synthesis and applications (10 papers), Synthesis and Reactivity of Heterocycles (8 papers), Analytical Methods in Pharmaceuticals (7 papers), Analytical Chemistry and Chromatography (7 papers), Peptidase Inhibition and Analysis (7 papers) and Carbohydrate Chemistry and Synthesis (6 papers). The work is most often cited by research in Molecular Medicine (152 citations), Applied Microbiology and Biotechnology (44 citations), Pharmaceutical Science (86 citations), Organic Chemistry (392 citations) and Microbiology (74 citations). U. Urleb has collaborated with scholars based in Slovenia, France and Germany. Frequent co-authors include Stanislav Gobec, Miha Kotnik, Didier Blanot, Martin Everett, Mark H. Wilcox, Tomaž Bratkovič, Christopher J. Schofield, Patrice Courvalin, Tom Šolmajer and Michael J. Dawson. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron, SLAS DISCOVERY, Biochemical and Biophysical Research Communications and Chirality.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.